TMates
Status: Reported · 2 row(s) on file · checked 2026-08-21
A data file, not a finished review: the prices below are third-party Reported figures with their source and check date. They move to First-party only after our own dated walk of TMates's pages — and this page will say so when they do.
Reported pricing on file · semaglutide, tirzepatide
- Semaglutide
- from $158/mo — 12-mo plan; ($249 month-to-month)
- Tirzepatide
- from $167/mo — 12-mo plan; ($297 month-to-month)
- Provenance
- rangeyourself.com · checked 2026-08-21
Provider scorecard — the fields the sprint fills
| Pharmacy on file | not yet on file — queued |
| Pharmacy type | queued |
| States served | queued — unconfirmed coverage keeps state pages noindexed |
| Membership · consult fee | queued · queued |
| Dose-change policy | queued |
| Cancellation terms | queued |
| Shipping | queued |
| Intro price (first month/period) | — |
| Medication included in price | — not separately recorded |
| Offer conditions on file | — |
| Offer expiry / scheduled recheck | — |
| Support-response test | pending — standardized three-question timed email test, per the sprint |
| Cancellation walkthrough | pending — scripted cancel-and-document test, per the sprint |
| Update history | row verified/recorded 2026-08-21 · file regenerated 2026-09-20 |
Watch-outs recorded by trackers
- No watch-outs recorded yet.
What we have not verified
The standing (non-promo) rate at every dose; whether the figure is all-inclusive; the dispensing pharmacy and its 503A/503B status; state availability; cancellation terms. Until those are recorded first-party, TMates appears in ranked tables at its reported figure with a Reported chip, never a Verified one — the same rule applied to every program here, including every partner program — placements are labeled “Editor’s Pick” and disclosed.
No outbound link: we have not confirmed this program's canonical domain first-party, and we do not guess URLs.